Skip to content

Insider · CIK 0001650322

Dallas Jayson Donald Alexander

Reports to the SEC for 4 companies · COPENHAGEN N G7, G7

Transactions

50

Companies

4

Filings

10

CIK

0001650322

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2025-06-18DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award—
2024-06-20DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award—
2023-06-17DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award—
2022-06-14DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award—
2022-03-11ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer—
2022-03-11ARENA PHARMACEUTICALS INCJ Other—
2022-03-11ARENA PHARMACEUTICALS INCJ Other—
2022-03-11ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer—
2022-03-11ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer—
2022-03-11ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer—
2022-03-11ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer—
2022-03-11ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer—
2022-03-11ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer—
2021-06-15ARENA PHARMACEUTICALS INCS Sale−$81.2K
2021-06-11ARENA PHARMACEUTICALS INCStock Option (right to buy)A Award—
2021-06-11ARENA PHARMACEUTICALS INCA Award—
2021-05-26DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award—
2021-01-19ARENA PHARMACEUTICALS INCS Sale−$107K
2020-12-11ARENA PHARMACEUTICALS INCP Purchase+$346.546
2020-12-08ARENA PHARMACEUTICALS INCP Purchase+$331.24
2020-11-19DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award—
2020-11-19DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award—
2020-10-13Aimmune Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer−$1.34M
2020-10-13Aimmune Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer−$2.26M
2020-10-13Aimmune Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer−$2.14M
2020-10-13Aimmune Therapeutics, Inc.D Disposition to Issuer−$3.08M
2020-10-10Aimmune Therapeutics, Inc.U Disposition from Tender−$1.05M
2020-09-15Aimmune Therapeutics, Inc.F Tax Payment−$56.2K
2020-06-22Aimmune Therapeutics, Inc.F Tax Payment−$142K
2020-06-12ARENA PHARMACEUTICALS INCStock Option (right to buy)A Award—
2020-06-12ARENA PHARMACEUTICALS INCA Award—
2020-05-10Aimmune Therapeutics, Inc.A Award—
2020-03-10Aimmune Therapeutics, Inc.P Purchase+$49.9K
2020-03-02Aimmune Therapeutics, Inc.F Tax Payment−$73.4K
2020-02-28Aimmune Therapeutics, Inc.A Award—
2020-02-28Aimmune Therapeutics, Inc.Stock Option (right to buy)A Award—
2019-06-19Aimmune Therapeutics, Inc.F Tax Payment−$161K
2019-06-14ARENA PHARMACEUTICALS INCS Sale−$75.6K
2019-06-14ARENA PHARMACEUTICALS INCS Sale−$9,606.394
2019-06-13ARENA PHARMACEUTICALS INCStock Option (right to buy)A Award—
2019-06-13ARENA PHARMACEUTICALS INCA Award—
2019-02-22Aimmune Therapeutics, Inc.Stock Option (right to buy)A Award—
2019-02-22Aimmune Therapeutics, Inc.A Award—
2018-11-19Aimmune Therapeutics, Inc.P Purchase+$99.2K
2018-11-19Aimmune Therapeutics, Inc.P Purchase+$1,377.995
2018-06-19Aimmune Therapeutics, Inc.A Award—
2018-06-19Aimmune Therapeutics, Inc.Stock Option (right to buy)A Award—
2018-06-13ARENA PHARMACEUTICALS INCA Award—
2018-06-13ARENA PHARMACEUTICALS INCStock Option (right to buy)A Award—
2018-06-01RAREUltragenyx Pharmaceutical Inc.F Tax Payment−$21.7K